Biomeme, Inc.
DNA analysis in the palm of your hand - anyone, anywhere.
DNA analysis in the palm of your hand - anyone, anywhere.
Biomeme is a biotechnology company that was founded in 2012. The company operates within the Biotechnology and Health Care industries. Their recent financial boost came in the form of a Convertible Note investment on 11 March 2024, with Robin Hood Ventures being the participating investors. With their focus on leveraging technology in the biotech and healthcare sectors, Biomeme continues to attract attention and funding from notable investors.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Convertible Note | Unknown | 1 |
|
11 Mar 2024 |
| Venture Round | Unknown | 1 |
|
01 Jan 2022 |
| Convertible Note | $131.63K | 1 |
|
29 Jul 2020 |
| Non Equity Assistance | Unknown | 1 |
|
03 Apr 2016 |
| Debt Financing | $992.80K | - | 29 Jan 2014 |
No recent news or press coverage available for Biomeme, Inc..
We care about your data, and we'd love to use cookies make your experience better.
